Integrative Research Laboratories Ab

This trial tests whether a drug called pirepemat can reduce how often people with Parkinson's disease fall. Participants take the drug or a placebo for 84 days and record falls in a diary. The study includes people aged 55–85 who have had at least two falls in the past month. If …

This early-stage trial tested the safety of a new drug, IRL757, in 82 healthy adults aged 18-55. Participants received either single or multiple doses of the drug or a placebo. The study focused on side effects and how the drug moves through the body, not on treating any disease.

This early-stage study tested a new drug called IRL757 in 12 healthy volunteers aged 65 to 89. The goal was to see how the drug is processed in the body and check for any safety issues. No treatment for any disease was given; this is a first step to gather information for future …